Abstract

ObjectiveTo analyze the results of treatment of scaphoid nonunion with questionable viability of the proximal fragment, but without significant deformity or collapse, using a vascularized bone graft of 1,2 intercompartmental supraretinacular artery (1,2 ICSRA) and subsequent osteosynthesis. Materials and methodsA retrospective study was performed on 10 male patients with a radiographic diagnosis of nonunion. Functionality, pain using Visual Analog Score (VAS), grip strength, patient satisfaction and reintroduction to working life, using QuickDASH and may specific wrist scales were assessed after the treatment. The integration of the graft was checked by radiography. ResultsThe mean follow-up was 31.4 months, and 90% of the questionnaires were satisfactory. The VAS decreased by 4.6 points and the flexor-extensor mobility gain was 5°. The total graft consolidation rate reached 40% in 5.5 months on average. DiscussionSeveral studies have demonstrated better results using vascularized bone graft versus non-vascularized. From the description by Zaidemberg in 1991, the vascularized graft with 1,2 ICSRA artery, distal radius, has been the most widely used for the treatment of scaphoid nonunion. ConclusionsOur results are comparable with the literature reviewed; thus using vascular graft of the 1,2 ICSRA and osteosynthesis with Herbert-type screw may be an alternative treatment for proximal scaphoid nonunion, without collapse or significant deformity.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.